期刊文献+

Akt2特异性siRNA对人肺癌细胞化疗敏感性及耐药性的影响 被引量:4

Effects of Akt2-siRNA on chemotherapeutic sensitivity and drug resistance in human lung cancer cells
原文传递
导出
摘要 目的探讨癌基因蛋白质v-akt(Akt2)特异性siRNA对人肺癌细胞株NCI—H446细胞顺铂化疗敏感性的影响及对耐药蛋白的调控作用。方法构建针对Akt2基因mRNA的siRNA,利用脂质体转染肺癌细胞NCI-H446,反转录-PCR检测Akt2-mRNA的表达,免疫细胞化学法检测肺耐药相关蛋白(LRP)及P糖蛋白(P-gP)的表达。以顺铂分别作用于对照组、未转染组、阴性质粒组及转染组细胞24h后,噻唑蓝(MTr)比色法检测细胞的增殖,流式细胞仪检测细胞的凋亡。结果转染Akt2-siRNA后,NCI-H446细胞Akt2-mRNA表达明显降低,转染组肺癌细胞LRP及P-gP表达水平显著低于未转染组(P〈0.01)。细胞的增殖率从(60.2±2.8)%下降到(34.7±2.6)%(P〈0.01),凋亡率从(19.3±1.6)%上升到(38.8±1.2)%(P〈0.01)。结论Akt2特异性siRNA可明显下调Akt2的表达,提高NCI—H446细胞对化疗的敏感性;它可能是通过下调LRP和P—gp蛋白的表达,部分逆转NCI-H446细胞对顺铂的耐药性。 Objective To explore the effects of oncogene protein v-akt-siRNA on the sensitivity of human lung cancer cell line NCI-H446 to cisplatin and drug resistance proteins in human lung cancer ceils. Methods The small interfering siRNA expression vector targeting Akt2 gene (siAkt2) was constructed. And the NCI-H446 cells were transfected with negative control vector or siRNA vector. The expressions of Akt2-mRNA and lung resistance-related protein (LRP) and P-glycoprotein (P-gp) were detected by reverse transcription-polymerase chain reaction and immunocytochemistry respectively. NCI- H446 and transfected cells were treated by cisplatin for 24 h. The cell proliferation was measured by 3- (4, 5-cimethylthiazol-2-yl)-2,5-diphenyl tetrazolium (MTT) assay and cell apoptotic rate detected by flow cytometry. Results Akt2-mRNA decreased significantly in the transfected NCI-H446 cells versus the non- transfection group. And the expressions of LRP and P-gp proteins decreased significantly in the transfection group versus the control group (P 〈 0. 01 ). The cell proliferation rate decreased from (60. 2 ± 2. 8) % to (34.7 ±2.6)% (P〈0.01). The cell apoptotic rate increased from (19.3 ±1.6)% to (38.8 ±1.2)% after a therapy of cisplatin ( P 〈 0. 01 ). Conclusion The siRNA targeting Akt2 can decrease the Akt2 expression, increase the chemotherapeutic sensitivity to cisplatin and partially reverse the cisplatin resistance of NCI-H446. The mechanism may be through the lowered expressions of LRP and P-gp.
出处 《中华医学杂志》 CAS CSCD 北大核心 2011年第30期2139-2142,共4页 National Medical Journal of China
基金 河南省医学高新技术发展扶持项目(20060035)
关键词 肺肿瘤 RNA 小分子干扰 癌基因蛋白质v—akt 顺铂 抗药性 肿瘤 Lung neoplasms RNA, small interfering Oncogene protein v-akt Cisplatin Drug resistance, neoplasmic
  • 相关文献

参考文献13

  • 1McAuliffe PF, Meric-Bemstam F, Mills GB, et al. Deciphering the role of PI3K/Akt/mTOR pathway in breast cancer biology and pathogenesis. Clin Breast Cancer, 2010, 10 Suppl 3: S59-S65.
  • 2邢传平,刘斌,董亮.免疫组织化学标记结果的判断方法[J].中华病理学杂志,2001,30(4):318-318. 被引量:206
  • 3Szakacs G, Paterson JK, Ludwig JA, et al. Targeting muhidrug resestance in cancer. Nat Rev Drug Discov, 2006, 5: 219-234.
  • 4Ma J, Sawai H, Ochi N, et al. PTEN regulates angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells. Mol Cell Biochem, 2009, 331 : 161-171.
  • 5Tommasi S, Pinto R, Pilato B, et al. Molecular pathways and related target therapies in liver carcinoma. Curr Pharm Des, 2007, 13: 3279-3287.
  • 6刘建平,袁世珍,张世能.小干扰RNA沉默MAT1基因治疗胰腺癌的实验研究[J].中华医学杂志,2007,87(38):2719-2723. 被引量:6
  • 7Zhang HY, Zhang PN, Sun H. Aberration of the PI3K/Akt/ mTOR signaling in epithelial ovarian cancer and its implication in cisplatin-based chemotherapy. Eur J Obstet Gynecol Reprod Biol, 2009, 146: 81-86.
  • 8Garcia MG, Alaniz LD, Cordo Russo RI, et al. PI3K/Akt inhibition modulates muhidrug resistance and activates NF-kappaB in murine lymphoma cell lines. Leuk Res, 2009, 33 : 288-296.
  • 9Choi BH, Kim CG, Lim Y, et al. Curcumin down-regulates the multidrug-resistance mdrlb gene by inhibiting the PI3K/Akt/NF kappa B pathway. Cancer Lett, 2008, 259: 111-118.
  • 10Liu F, Liu S, He S, et al. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells. Oncol Rep, 2010, 23: 1469-1475.

二级参考文献12

  • 1刘建平,袁世珍.“分子开关”MAT1基因的研究进展[J].国外医学(生理病理科学与临床分册),2004,24(4):306-308. 被引量:4
  • 2刘建平,袁世珍,张世能,詹俊,朱兆华.胰腺癌中MAT1蛋白的表达与其临床病理特征的关系[J].中国病理生理杂志,2005,21(1):163-166. 被引量:6
  • 3张世能,徐凤琴,黄志清,曾志勇,袁世珍.反义MAT1重组腺病毒对人胰腺癌细胞BxPC-3的周期调控作用[J].中华医学杂志,2005,85(19):1348-1351. 被引量:9
  • 4Zamore PD, Tuschl T, Sharp PA, et al. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell,2000, 101 : 25-33.
  • 5Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21- nucleotide RNAs mediates RNA interference in cultured mammalian cells. Nature ,2001,411 : 494--498.
  • 6Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 1998, 391 : 806-811.
  • 7Harborth J, Elbashir SM, Bechert K, et al. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J Cell Sci, 2001, 114(Pt 24) : 4557-4565.
  • 8Svoboda P, Stein P, Hayashi H, et al. Selective reduction of dormant maternal mRNAs in mouse oocytes by RNA interference. Development, 2000, 127 : 4147-4156.
  • 9Rossi DJ, Londesborough A, Korsisaari N, et al. Inability to enter S phase and defective RNA polymerase Ⅱ CTD phosphorylation in mice lacking Matl. EMBO J, 2001,20: 2844-2856.
  • 10Wu L, Chen P, Shum CH, et al. MAT1-modulated CAK activity regulates cell cycle G (1) exit. Mol Cell Biol, 2001, 21: 260-270.

共引文献210

同被引文献36

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部